Compare HPP & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HPP | LAB |
|---|---|---|
| Founded | 1997 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 553.0M | 488.4M |
| IPO Year | 2010 | 2011 |
| Metric | HPP | LAB |
|---|---|---|
| Price | $8.23 | $1.32 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $17.27 | $1.35 |
| AVG Volume (30 Days) | 1.2M | ★ 1.5M |
| Earning Date | 02-26-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $781,676,000.00 | $169,737,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 79.77 |
| 52 Week Low | $8.12 | $0.92 |
| 52 Week High | $23.52 | $1.72 |
| Indicator | HPP | LAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 38.41 |
| Support Level | $8.62 | $1.36 |
| Resistance Level | $9.00 | $1.46 |
| Average True Range (ATR) | 0.41 | 0.09 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 5.29 | 4.06 |
Hudson Pacific Properties Inc is a real estate investment trust that acquires, operates, and owns office buildings and media and entertainment properties, such as sound stages, on America's West Coast. The company focuses on developed, urban markets in Northern California, Southern California, and the Pacific Northwest. In terms of total square footage, the vast majority of Hudson Pacific's real estate portfolio is composed of office properties located in the Greater Seattle, San Francisco, and Los Angeles areas. The company operates in two reportable segments; office properties & related operations; and studio properties & related operations. The majority of revenue is derived from the office properties & related operations segment.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.